Research and development expenses (excluding stock-based compensation)
Mirum Pharmaceuticals, Inc.·Business Segments·1 segment
Breakdown
Segments
Business SegmentsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Business Segments | $35.82M | $38.44M | $37.28M | $45.48M | $73.72M |
| Total | $35.82M | $38.44M | $37.28M | $45.48M | $73.72M |